Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 08/19/19 → 06/11/21 |
Funding
- PTC Therapeutics Inc: $10,450.00
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Ataluren in Patients with Nonsense Mutation Duchenne Muscular Dystrophy and Open-Label Extension
- Treidler, Simona (PI)
- Cruz, Elizabeth (CoPI)
Project: Research